Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
2.410
-0.200 (-7.66%)
At close: Sep 17, 2025, 4:00 PM EDT
2.520
+0.110 (4.57%)
After-hours: Sep 17, 2025, 4:13 PM EDT

Company Description

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets.

It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.

The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023.

Medicus Pharma Ltd. was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.

Medicus Pharma Ltd.
Medicus Pharma logo
CountryUnited States
Founded2008
IndustryDrug Manufacturers - General
SectorHealthcare
CEORaza Bokhari

Contact Details

Address:
300 Conshohocken State Road, Suite 200
Conshohocken, Pennsylvania 19428
United States
Phone(610) 540-7515
Websitemedicuspharma.com

Stock Details

Ticker SymbolMDCX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001997296
ISIN NumberCA58471K2020
Employer ID98-1778211
SIC Code2834

Key Executives

NamePosition
Dr. Raza Bokhari M.B.A., M.D., MBAChief Executive Officer and Executive Chairman
James P. Quinlan CPAChief Financial Officer
Andrew Alasdair SmithChief Operating Officer
Anna Baran-Djokovic J.D.Senior Vice President of Investor Relations
Viktoriia SlepeniukSenior Vice President of Public Relations
Dr. Faisal Mehmud M.D.Chief Medical Officer
Maryann AdessoChief of Staff and Corporate Secretary

Latest SEC Filings

DateTypeTitle
Sep 15, 2025424B3Prospectus
Sep 15, 2025424B3Prospectus
Sep 15, 2025253G2Acc-no: 0001493152-21-027927 (33 Act)
Sep 15, 2025424B3Prospectus
Sep 12, 20258-KCurrent Report
Sep 2, 2025424B3Prospectus
Sep 2, 2025424B3Prospectus
Sep 2, 2025424B3Prospectus
Sep 2, 2025253G2Acc-no: 0001493152-21-027927 (33 Act)
Sep 2, 20258-KCurrent Report